113 related articles for article (PubMed ID: 33425801)
1. Evaluation of the pharmacokinetics and food effects of a novel formulation tamsulosin 0.4 mg capsule compared with a 0.2 mg capsule in healthy male volunteers.
Ban MS; Kim YK; Kim B; Jung J; Kim YI; Oh J; Yu KS
Transl Clin Pharmacol; 2020 Dec; 28(4):181-188. PubMed ID: 33425801
[TBL] [Abstract][Full Text] [Related]
2. Relative Bioavailability of Fixed-Dose Combinations of Tamsulosin and Dutasteride: Results From 2 Randomized Trials in Healthy Male Volunteers.
Burns O; Zhu J; Manyak MJ; Ravindranath R; Koosha F; Haque N; Chung S
Clin Pharmacol Drug Dev; 2018 May; 7(4):422-434. PubMed ID: 28800206
[TBL] [Abstract][Full Text] [Related]
3. Bioequivalence Studies of a Reformulated Dutasteride and Tamsulosin Hydrochloride Combination Capsule and a Commercially Available Formulation.
Kurczewski R; Bowen C; Collins D; Zhu J; Serbest G; Manyak M
Clin Pharmacol Drug Dev; 2017 Sep; 6(5):508-516. PubMed ID: 28127948
[TBL] [Abstract][Full Text] [Related]
4. Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects.
Kim HC; Yang E; Lee S; Oh J; Lee M; Lee C; Ha KS; Lee WS; Jang IJ; Yu KS
Invest New Drugs; 2024 Feb; 42(1):80-88. PubMed ID: 38099989
[TBL] [Abstract][Full Text] [Related]
5. Effects of meal type on the bioavailability of vutiglabridin, a novel anti-obesity agent, in healthy subjects.
Won H; Yoon DY; Lee S; Cho JY; Oh J; Jang IJ; Yoo SK; Yu KS
Clin Transl Sci; 2024 Mar; 17(3):e13744. PubMed ID: 38436494
[TBL] [Abstract][Full Text] [Related]
6. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
Gandelman K; Lamson M; Salageanu J; Bramson C; Matschke K; Malhotra B
Clin Pharmacol Drug Dev; 2015 Sep; 4(5):370-6. PubMed ID: 27137146
[TBL] [Abstract][Full Text] [Related]
7. Effect of food on the pharmacokinetics of clozapine orally disintegrating tablet 12.5 mg: a randomized, open-label, crossover study in healthy male subjects.
Disanto AR; Golden G
Clin Drug Investig; 2009; 29(8):539-49. PubMed ID: 19591515
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic bioequivalence studies of a fixed-dose combination of tamsulosin and dutasteride in healthy volunteers.
Fossler MJ; Collins DA; Thompson MM; Nino A; Bianco JJ; Chetty D
Clin Drug Investig; 2014 May; 34(5):335-49. PubMed ID: 24615171
[TBL] [Abstract][Full Text] [Related]
9. Effect of a high-fat meal on the relative bioavailability of H3B-6527, a novel FGFR4 inhibitor, in healthy volunteers.
Rioux N; Kim A; Nix D; Bowser T; Warmuth M; Smith PG; Schindler J
Cancer Chemother Pharmacol; 2019 Jan; 83(1):91-96. PubMed ID: 30368584
[TBL] [Abstract][Full Text] [Related]
10. Effects of food intake on the pharmacokinetic properties of mirabegron oral controlled-absorption system: a single-dose, randomized, crossover study in healthy adults.
Lee J; Zhang W; Moy S; Kowalski D; Kerbusch V; van Gelderen M; Sawamoto T; Grunenberg N; Keirns J
Clin Ther; 2013 Mar; 35(3):333-41. PubMed ID: 23497763
[TBL] [Abstract][Full Text] [Related]
11. A pharmacokinetic and bioequivalence study of Contiflo ICON 400 µg tablets in healthy Indian subjects.
Monif T; Arora V; Madan S; Arora R; Balaji A; Jha D; Thudi NR
Int J Clin Pharmacol Ther; 2010 Dec; 48(12):868-76. PubMed ID: 21084043
[TBL] [Abstract][Full Text] [Related]
12. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
13. Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) under fed and fasted conditions: two randomized open-label trials.
Devarakonda K; Kostenbader K; Giuliani MJ; Young JL
BMC Pharmacol Toxicol; 2015 Nov; 16():31. PubMed ID: 26614499
[TBL] [Abstract][Full Text] [Related]
14. Effect of food on the pharmacokinetics of YH4808, a potassium-competitive acid blocker, after single- and multiple-oral dosing in healthy subjects.
Kim E; Kim A; Yi S; Kim YK; Jang SB; Byun HM; Yoon SH; Cho JY; Jang IJ; Yu KS; Lee S
Eur J Clin Pharmacol; 2018 Oct; 74(10):1261-1272. PubMed ID: 29907887
[TBL] [Abstract][Full Text] [Related]
15. Comparative Pharmacokinetics of a Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and an Immediate-release Pregabalin Capsule in Healthy Male Volunteers.
Kim TE; Jeon JY; Gu N; Chang Kwon M; Kim MG
Clin Ther; 2018 Dec; 40(12):2112-2124. PubMed ID: 30497798
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of food effects on the pharmacokinetics of
Park Y; Jung W; Yang E; Nam KY; Bong WR; Kim J; Kim KY; Lee S; Cho JY; Hong JH; Kim J
Transl Clin Pharmacol; 2022 Mar; 30(1):49-56. PubMed ID: 35419311
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of a Lobeglitazone/Metformin Fixed-Dose Combination Tablet (CKD-395 0.5/1000 mg) Versus Concomitant Administration of Single Agents and the Effect of Food on the Metabolism of CKD-395 in Healthy Male Subjects.
Kim SY; Jeon JY; Park SJ; Kim MG
Clin Pharmacol Drug Dev; 2019 Jul; 8(5):576-584. PubMed ID: 30329224
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
Sikes C; Stark JG; McMahen R; Engelking D
Clin Ther; 2017 Dec; 39(12):2389-2398. PubMed ID: 29174216
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effects of formulation, food, or a proton-pump inhibitor on the pharmacokinetics of glasdegib (PF-04449913) in healthy volunteers: a randomized phase I study.
Shaik N; Hee B; Wei H; LaBadie RR
Cancer Chemother Pharmacol; 2019 Mar; 83(3):463-472. PubMed ID: 30536154
[TBL] [Abstract][Full Text] [Related]
20. Effect of food on the pharmacokinetic characteristics of a single oral dose of LCB01-0371, a novel oxazolidinone antibiotic.
Sunwoo J; Kim YK; Choi Y; Yu KS; Nam H; Cho YL; Yoon S; Chung JY
Drug Des Devel Ther; 2018; 12():1707-1714. PubMed ID: 29928114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
